Filing Details

Accession Number:
0001179110-10-009472
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-05-27 13:00:00
Reporting Period:
2010-05-26
Filing Date:
2010-05-27
Accepted Time:
2010-05-27 19:15:50
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1142596 Nuvasive Inc NUVA Surgical & Medical Instruments & Apparatus (3841) 330768598
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1345767 P Jeffrey Rydin 7475 Lusk Blvd.
San Diego CA 92121
Evp, Sales, Americas No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-05-26 2,995 $17.91 5,622 No 4 M Direct
Common Stock Disposition 2010-05-26 2,995 $40.47 2,627 No 4 S Direct
Common Stock Acquisiton 2010-05-26 5 $23.24 2,632 No 4 M Direct
Common Stock Disposition 2010-05-26 5 $40.47 2,627 No 4 S Direct
Common Stock Acquisiton 2010-05-26 1,000 $23.24 3,627 No 4 M Direct
Common Stock Disposition 2010-05-26 1,000 $40.00 2,627 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2010-05-26 2,995 $0.00 2,995 $17.91
Common Stock Stock Option (Right to Buy) Disposition 2010-05-26 1,005 $0.00 1,005 $23.24
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
4,069 2009-12-05 2015-12-05 No 4 M Direct
58,067 2017-01-16 No 4 M Direct
Footnotes
  1. The shares sold were acquired contemporaneously upon the cashless exercise of a stock option at an exercise price of $17.91 per share.
  2. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13,2009.
  3. The shares sold were acquired contemporaneously upon the cashless exercise of a stock option at an exercise price of $23.24 per share.
  4. Includes 713 shares acquired by the Reporting Person under the Issuer's Employee Stock Purchase Plan on April 30, 2010 in a transaction exempt from reporting under Rule 16b-3.
  5. 25% of the total shares subject to the option vested on January 16, 2008 which was the first anniversary of the date of the grant; the remaining shares vest in 36 equal monthly installments thereafter.